| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_830546519f5f26ac1c4c6d577378e060 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 |
| filingDate |
2008-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2010-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95ca4911f2bbd5cb437eef057b821f02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d67858401a94027f095784a440073dfc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_023c2d064957be74a222b6747b51615b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6768a6600d4f3ee2f9d21c7a52c7ad32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5965a360a417e3aef8dc4a41ed0354f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b98553ae031e568be085278e8e3b5396
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_152c40e837ef5dd14a82757ef40b06bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e66a1b62b10d528d5bb4b22aff27525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec1e0ac4195caec41e7e9317048e9374
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0cc3354b36eedfc21be6a5af89eeca2f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0677a1c4e2afb15db22cb797cf65736c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_305772579743ef3389bb2dc8fcd45eb5 |
| publicationDate |
2010-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2395574-C1 |
| titleOfInvention |
Human melanoma cell line ilg which secretes recombinant granulocytic-macrophagal colony-stimulating factor |
| abstract |
FIELD: chemistry; biochemistry. n SUBSTANCE: invention relates to biotechnology, particularly to obtaining cell lines and can be used for immunotherapy and immunoprophylaxis in patients with malignant growths. The human melanoma cell line ILG has stable culture, morphological and immunological characteristics and can secrete a human recombinant granulocytic-macrophagal colony-stimulating factor (GM-CSF). The ILG cell line is deposited in the Special collection of cell cultures of vertebrates of the Russian collection of cell cultures under number RKKK (P) 697D. All cells of the ILG line are characterised by stable secretion of GM-CSF stored after inactivation of cells through exposure to 100 Gy of ionising radiation which reliably prevents proliferation of the inactivated cells. n EFFECT: invention enables introduction of inactivated tumour cells into patients in order to stimulate antitumuor immunity. |
| priorityDate |
2008-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |